Business
PROPOSED OFFERING IN HALEON PLC BY PFIZER INC.
PROPOSED OFFERING IN HALEON PLC BY PFIZER INC..
About this update from Haleon Plc
[{"type":"text","content":"\n\nNot for publication, release, transmission, forwarding or distribution, directly or indirectly, in whole or in part, in or into the United States, Australia, Canada, Japan or South Africa or in any other jurisdiction in which offers or sales would be prohibited by applicable law.\nThis announcement is for information purposes only and is not a prospectus or an offer of securities for sale in any jurisdiction.\nNeither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Any offer to acquire securities pursuant to the Offering (as defined below) will be made, and any investor should make its investment decision solely on the basis of, publicly available information. There will be no sale of the securities referred to herein in any jurisdiction where such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.\nPlease see the important notice at the end of this announcement.\nPROPOSED SECONDARY OFFERING OF ORDINARY SHARES IN HALEON PLC BY PFIZER INC.\n18 March 2025: Pfizer Inc. (\"Pfizer\") today announces that it intends to sell, in aggregate, approximately 662 million ordinary shares (\"Ordinary Shares\") in Haleon plc (\"Haleon\"), representing approximately 7.3% of Haleon's issued share capital and representing Pfizer's entire residual shareholding in Haleon, pursuant to the Offering and the Share Buyback (each as defined below) (collectively, the \"Disposal\"). This announcement is not and does not constitute an offer to sell and there will be no public offering of the Sale Shares (as defined below) in any jurisdiction. Pfizer has no residual holding of Ordinary Shares in the form of American depositary shares in Haleon and there will be no sale of any Ordinary Shares in the form of American depositary shares in Haleon.\nThe Offering\nPfizer intends to sell Ordinary Shares to institutional investors (the \"Offering\", and such Ordinary Shares in the Offering, the \"Sale Shares\"), with the price per Sale Share in the Offering (the \"Offering Price\") to be determined by way of an accelerated bookbuilding process. The bookbuilding period will commence immediately following this announcement and may close at any time on short notic...